Reneo Pharmaceuticals Stock Story
| RPHM Stock | USD 1.69 0.05 2.87% |
About 67% of Reneo Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Reneo Pharmaceuticals suggests that many traders are alarmed. Reneo Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Reneo Pharmaceuticals. The current market sentiment, together with Reneo Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Reneo Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Reneo Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Reneo daily returns and investor perception about the current price of Reneo Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Reneo |
Requested story not found. it has been either deleted or moved. View all stories for Reneo Pharmaceuticals.
Reneo Pharmaceuticals Latest Timeline
Reneo Pharmaceuticals is listed for 1.69. About 82.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.65. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Reneo Pharmaceuticals recorded a loss per share of 2.52. The entity had not issued any dividends in recent years.Check out Reneo Pharmaceuticals Hype Analysis, Reneo Pharmaceuticals Correlation and Reneo Pharmaceuticals Performance. To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.Note that the Reneo Pharmaceuticals information on this page should be used as a complementary analysis to other Reneo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Reneo Stock analysis
When running Reneo Pharmaceuticals' price analysis, check to measure Reneo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reneo Pharmaceuticals is operating at the current time. Most of Reneo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reneo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reneo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reneo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Reneo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reneo Pharmaceuticals. If investors know Reneo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reneo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.52) | Return On Assets (0.48) | Return On Equity (0.82) |
The market value of Reneo Pharmaceuticals is measured differently than its book value, which is the value of Reneo that is recorded on the company's balance sheet. Investors also form their own opinion of Reneo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reneo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reneo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reneo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reneo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reneo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reneo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.